A combination formulation of the sodium salts of the antibiotic ampicillin and the beta-lactamase inhibitor sulbactam with antibacterial activity.
Ampicillin, a broad-spectrum, semisynthetic penicillin, binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall, thereby interfering with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. As a result, the cell wall is weakened and the cell lyses.
The sulbactam component irreversibly binds to bacterial beta-lactamase at or near its active site, thereby interfering with substrate binding and inhibiting bacterial metabolism of penicillin and cephalosporin beta-lactam antibiotics, effectively extending their antibiotic spectrum to include many beta-lactam-resistant bacteria.
As COVID-19 impacts families, communities, and public health systems all over the world, we are challenged to commit still more deeply to our vision of a world free from health-related suffering. The IAHPC is working hard to strengthen our networks and prepare our membership to meet the unprecedented spike in demand.
This month we are asking our readers to donate a small amount. We are a not for profit organization dedicated to the advancement of hospice and palliative care in the world to alleviate serious health related suffering of millions of patients and families around the world.
We have many visitors to this website. If everyone could donate US$ 3, we could meet the additional expenses that we are facing. Please consider donating to help our work and to keep our organization running for you, and thousands like you around the world.